Meaning
Measurement of the chemical interaction between specific molecules and genetic material to assess potential toxicological risks. Testing for deoxynucleic acid reactivity is a standard requirement for polymers intended for long term medical implantation or food contact. This assessment identifies whether migrants from the plastic can alter the structure of biological cells.
Migrant Evaluation
Small molecules like residual monomers or plasticisers sometimes escape the polymer matrix during use in a biological environment. If these substances show measurable deoxynucleic acid reactivity, the resin is deemed unsuitable for applications involving direct tissue contact or blood flow. Lab studies use high sensitivity assays to detect even minor binding events between the chemical and the genetic target to ensure long term patient safety.
Risk Assessment
Regulatory bodies use the results of these tests to set migration limits for new polymer formulations. Because deoxynucleic acid reactivity varies by chemical structure, a moulder must select resins that have already passed extensive biocompatibility screening. This selection prevents future liability and ensures the safety of the end user in medical environments.
Polymer Stability
High energy sterilisation processes like gamma irradiation can break down polymer chains into reactive fragments. Monitoring deoxynucleic acid reactivity after such treatments reveals whether the processing changed the safety profile of the part. Stable materials maintain a low profile throughout the entire lifecycle of the medical device.
